FDA Inspection Readiness Assessment Checklist
FDA inspection readiness is an ongoing state requiring systematic preparation. This readiness assessment identifies gaps before an inspection and ensures the site can present accurate, current compliance documentation.
- Industry: Pharmaceutical
- Frequency: Semi-Annual
- Estimated Time: 60-90 minutes
- Role: Quality Director / Regulatory Affairs Manager
- Total Items: 31
- Compliance: FDA 21 CFR Parts 210/211 cGMP Requirements, FDA Compliance Program Guidance Manual (CPGM) 7356.002 - Drug Manufacturing Inspections, FDA Pharmaceutical Quality System (PQS) Inspection Approach, EMA GMP Inspection Guidelines
Quality System Readiness
Assess overall quality system health.
- No critical or major open CAPAs, deviations, or OOS without resolution plan?
- Annual Product Quality Review (APQR) current for all commercial products?
- Quality trend data showing no adverse trends requiring escalation?
- Management reviews completed per ICH Q10 with documented outcomes?
- Quality metrics (right first time, OOS rate, CAPA timeliness) within acceptable targets?
Facility and Documentation Readiness
Verify facility and documentation are ready.
- Manufacturing areas clean, orderly, and presenting well to inspector?
- Site Master File (SMF) current and reflects actual operations?
- Batch records for recent batches readily retrievable?
- Process validation, equipment qualification, and cleaning validation current?
- All SOPs current, properly formatted, and easily retrievable?
Personnel Preparation
Prepare personnel for inspector interaction.
- Key personnel briefed on inspection procedures and their roles?
- Designated scribe to document all inspector questions and requests?
- Inspection escort trained to accompany inspector and ensure access?
- Response room (war room) set up with document request workflow?
- Personnel coached on answering only what is asked, not volunteering information?
Known FDA Focus Areas
Address current FDA inspection focus areas.
- Data integrity program robust with ALCOA+ compliance demonstrated?
- Process understanding and control strategy documented per ICH Q8/Q9/Q10?
- Microbiological controls current with no concerning EM trends?
- Supplier qualification for all critical materials current?
- Water system qualification and monitoring current?
Previous 483 and Warning Letter Status
Verify previous regulatory action items addressed.
- All previous FDA 483 observations from last inspection closed with verified effectiveness?
- All warning letter commitments met with documented evidence?
- Any import alert resolved or corrective action plan current?
- Voluntary corrective actions for known issues documented and in progress?
- Mock FDA inspection conducted within past 12 months?
Inspection Logistics
Verify logistical preparation for inspection.
- FDA badge verification and visitor sign-in procedure ready?
- Personnel know to request FDA investigator credentials (FDA-2289)?
- Regulatory attorney contact information available for real-time consultation?
- 483 response team identified with process for drafting EIR response?
- Chain of command for inspection notifications defined and communicated?
- Inspection readiness assessment report prepared and distributed to management?
Related Pharmaceutical Life Sciences Checklists
- Pharmaceutical Product Recall Readiness Checklist
- FDA GMP Inspection Readiness Audit Checklist
- Annual Product Quality Review (APQR) Preparation Checklist
- Pharmaceutical Product Complaint Handling Checklist
- Pharmaceutical Incoming Material Sampling and Testing Checklist
- Pharmaceutical Cleanroom Environmental Monitoring Checklist
- Pharmaceutical Product Recall Readiness Checklist
- Pharmaceutical Daily Manufacturing Area Inspection Checklist
Related Regulatory Readiness Checklists
- GxP Training Compliance and Competency Audit Checklist - FREE Download
- Pharmaceutical Product Recall Readiness Checklist - FREE Download
- FDA GMP Inspection Readiness Audit Checklist - FREE Download
- Annual Product Quality Review (APQR) Preparation Checklist - FREE Download
- Pharmaceutical Product Complaint Handling Checklist - FREE Download
- Pharmaceutical Product Recall Readiness Checklist - FREE Download
Why Use This FDA Inspection Readiness Assessment Checklist?
This fda inspection readiness assessment checklist helps pharmaceutical teams maintain compliance and operational excellence. Designed for quality director / regulatory affairs manager professionals, this checklist covers 31 critical inspection points across 6 sections. Recommended frequency: semi-annual.
Ensures compliance with FDA 21 CFR Parts 210/211 cGMP Requirements, FDA Compliance Program Guidance Manual (CPGM) 7356.002 - Drug Manufacturing Inspections, FDA Pharmaceutical Quality System (PQS) Inspection Approach, EMA GMP Inspection Guidelines. Regulatory-aligned for audit readiness and inspection documentation.
Frequently Asked Questions
What is a FDA Inspection Readiness Assessment Checklist?
A FDA Inspection Readiness Assessment Checklist is a standardized inspection form used by quality director / regulatory affairs manager to ensure consistent pharmaceutical operations. It contains 39 inspection points organized into 6 sections. FREE FDA inspection readiness checklist PDF. Comprehensive FDA pre-inspection readiness assessment covering facility readiness, documentation organization, personnel preparation, known inspection focus areas, response room setup, and FDA 21 CFR Parts 210/211 compliance posture for pharmaceutical manufacturing sites preparing for FDA GMP inspections. Download FREE digital template now.
How often should I use this pharmaceutical checklist?
This checklist is designed to be completed semi-annual. Regular use ensures compliance with FDA 21 CFR Parts 210/211 cGMP Requirements and FDA Compliance Program Guidance Manual (CPGM) 7356.002 - Drug Manufacturing Inspections and helps identify issues before they become problems.
Can I download this FDA Inspection Readiness Assessment Checklist as a PDF?
Yes, you can download this checklist as a FREE PDF for printing or offline use. The checklist includes 39 fields across 6 sections and typically takes 60-90 minutes to complete.
What compliance standards does this checklist cover?
This checklist helps ensure compliance with FDA 21 CFR Parts 210/211 cGMP Requirements, FDA Compliance Program Guidance Manual (CPGM) 7356.002 - Drug Manufacturing Inspections, FDA Pharmaceutical Quality System (PQS) Inspection Approach, EMA GMP Inspection Guidelines. Following these standards protects your organization and ensures best practices.
How do I complete this pharmaceutical inspection checklist?
Begin by completing the header fields for Site Name, Assessment Date, Lead Assessor Name and Title, and Date of Last FDA Inspection. Work through each of the 6 sections, marking items Yes or No as applicable. Finally, complete the footer fields and add your signature. The entire process takes approximately 60 to 90 minutes.
What are the key sections in this pharmaceutical checklist?
This pharmaceutical checklist is organized into 6 key sections: Quality System Readiness, Facility and Documentation Readiness, Personnel Preparation, Known FDA Focus Areas, Previous 483 and Warning Letter Status, Inspection Logistics. Each section contains specific inspection points that quality director / regulatory affairs manager must verify. The structured layout ensures nothing is missed during pharmaceutical inspections and makes the process efficient, typically taking 60-90 minutes to complete.
Who should use this FDA Inspection Readiness Assessment Checklist?
This checklist is primarily designed for quality director / regulatory affairs manager working in pharmaceutical operations. However, it is also valuable for quality assurance teams, safety officers, compliance managers, and supervisors who need to verify that pharmaceutical standards are being met. Organizations of all sizes can benefit from using this FDA Inspection Readiness Assessment Checklist to maintain consistency and accountability.